Mk. Goenka et al., CANDIDA OVERGROWTH AFTER TREATMENT OF DUODENAL-ULCER - A COMPARISON OF CIMETIDINE, FAMOTIDINE, AND OMEPRAZOLE, Journal of clinical gastroenterology, 23(1), 1996, pp. 7-10
Acid-reducing drugs can cause increased growth of microbes, including
fungus, because of high gastric pH. Our purpose was to evaluate the oc
currence of mycotic infection in patients with duodenal ulcer on anti-
ulcer therapy and to compare the effects of cimetidine, famotidine, an
d omeprazole. Eighty patients with duodenal ulcer (62 males and 18 fem
ale patients, 16-65 years old) were evaluated for mycotic infection be
fore and after 6 weeks of therapy (cimetidine, 20 patients; famotidine
, 40 patients; omeprazole, 20 patients). Mycotic infection was diagnos
ed by endoscopic biopsy from the ulcer edge subjected to smear, cultur
e, and histopathology and by endoscopic brush samples and gastric aspi
rate. On the basis of these studies, patients were categorized as havi
ng no fungal growth, saprophytic growth, or significant fungal growth.
Thirty-five (43.8%) patients had evidence of fungus before ulcer ther
apy, and 16 of the 35 (20%) had significant fungal growth. The fungal
isolation rate was higher in older patients (greater than or equal to
45 years of age) and in those with an ulcer size greater than or equal
to 2 cm. While there was no significant increase in the total number
of patients with evidence of fungus after therapy (n = 36), there was
a significant increase in those with significant growth (n = 27, p < 0
.05) compared with pretreatment status. We found that posttreatment ga
stric pH of greater than or equal to 4 was associated with a higher fu
ngal positivity rate (59.4%) than pH values <4 (32.4%, p < 0.05). Howe
ver, neither the type of drug used nor the response in terms of ulcer
healing correlated with the presence of fungus. Regardless of the type
of drug used, acid-reducing therapy is associated with increased sign
ificant fungal growth.